Pharming Group Statistics

Total Valuation

Pharming Group has a market cap or net worth of $723.47 million. The enterprise value is $678.52 million.

Market Cap	723.47M
Enterprise Value	678.52M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

Pharming Group has 69.23 million shares outstanding. The number of shares has increased by 1.61% in one year.

Shares Outstanding	69.23M
Shares Change (YoY)	+1.61%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.07%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	169.49
PS Ratio	2.65
Forward PS	2.48
PB Ratio	3.08
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.49
EV / EBITDA	161.52
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.06, with a Debt / Equity ratio of 0.78.

Current Ratio	4.06
Quick Ratio	3.33
Debt / Equity	0.78
Debt / EBITDA	43.84
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -5.10% and return on invested capital (ROIC) is -1.38%.

Return on Equity (ROE)	-5.10%
Return on Assets (ROA)	-2.40%
Return on Capital (ROIC)	-1.38%
Revenue Per Employee	$713,543
Profits Per Employee	-$30,681
Employee Count	382
Asset Turnover	0.56
Inventory Turnover	0.51

Taxes

Income Tax	-1.57M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.78% in the last 52 weeks. The beta is 0.74, so Pharming Group's price volatility has been lower than the market average.

Beta (1Y)	0.74
52-Week Price Change	-3.78%
50-Day Moving Average	10.94
200-Day Moving Average	11.77
Relative Strength Index (RSI)	49.40
Average Volume (30 Days)	2,674

Short Selling Information

Short Interest	1,322
Short Previous Month	1,476
Short % of Shares Out	0.00%
Short % of Float	n/a
Short Ratio (days to cover)	0.59

Income Statement

In the last 12 months, Pharming Group had revenue of $272.57 million and -$11.72 million in losses. Loss per share was -$0.17.

Revenue	272.57M
Gross Profit	236.29M
Operating Income	-5.78M
Pretax Income	-12.90M
Net Income	-11.72M
EBITDA	4.20M
EBIT	-12.90M
Loss Per Share	-$0.17

Full Income Statement

Balance Sheet

The company has $229.12 million in cash and $184.16 million in debt, giving a net cash position of $44.96 million or $0.65 per share.

Cash & Cash Equivalents	229.12M
Total Debt	184.16M
Net Cash	44.96M
Net Cash Per Share	$0.65
Equity / Book Value	234.87M
Book Value Per Share	3.39
Working Capital	255.91M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.57 million and capital expenditures -$1.54 million, giving a free cash flow of -$20.12 million.

Operating Cash Flow	-18.57M
Capital Expenditures	-1.54M
Free Cash Flow	-20.12M
FCF Per Share	-$0.30

Full Cash Flow Statement

Margins

Gross margin is 86.69%, with operating and profit margins of -2.12% and -4.30%.

Gross Margin	86.69%
Operating Margin	-2.12%
Pretax Margin	-4.73%
Profit Margin	-4.30%
EBITDA Margin	1.54%
EBIT Margin	-4.73%
FCF Margin	-7.38%

Dividends & Yields

Pharming Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.61%
Shareholder Yield	-1.61%
Earnings Yield	-1.62%
FCF Yield	-2.78%

Analyst Forecast

The average price target for Pharming Group is $37.00, which is 254.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$37.00
Price Target Difference	254.07%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	14.66%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pharming Group has an Altman Z-Score of 1.94 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.94
Piotroski F-Score	2